KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 130 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $48,000 | -43.5% | 14,090 | -37.5% | 0.00% | – |
| Q2 2018 | $85,000 | -15.8% | 22,546 | -8.3% | 0.00% | – |
| Q1 2018 | $101,000 | -30.8% | 24,580 | -21.2% | 0.00% | – |
| Q4 2017 | $146,000 | -33.9% | 31,209 | 0.0% | 0.00% | – |
| Q3 2017 | $221,000 | +8.9% | 31,209 | +10.7% | 0.00% | – |
| Q2 2017 | $203,000 | +26.1% | 28,205 | +8.5% | 0.00% | – |
| Q1 2017 | $161,000 | +6.6% | 25,985 | +1.2% | 0.00% | – |
| Q4 2016 | $151,000 | +24.8% | 25,685 | +11.4% | 0.00% | – |
| Q3 2016 | $121,000 | -24.4% | 23,053 | -4.6% | 0.00% | – |
| Q2 2016 | $160,000 | +41.6% | 24,175 | 0.0% | 0.00% | – |
| Q1 2016 | $113,000 | -5.0% | 24,175 | -0.0% | 0.00% | – |
| Q4 2015 | $119,000 | +38.4% | 24,181 | 0.0% | 0.00% | – |
| Q3 2015 | $86,000 | -56.8% | 24,181 | +18.9% | 0.00% | – |
| Q2 2015 | $199,000 | -3.9% | 20,344 | +25.5% | 0.00% | – |
| Q1 2015 | $207,000 | +5.1% | 16,209 | +17.9% | 0.00% | – |
| Q4 2014 | $197,000 | +5.3% | 13,748 | 0.0% | 0.00% | – |
| Q3 2014 | $187,000 | – | 13,748 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Old West Investment Management, LLC | 1,068,719 | $3,633,000 | 1.50% |
| Abrams Capital Management | 9,108,867 | $30,970,000 | 0.82% |
| Baupost Group | 25,791,678 | $87,692,000 | 0.67% |
| Bristol Advisors, LLC | 51,100 | $174,000 | 0.29% |
| RICE HALL JAMES & ASSOCIATES, LLC | 2,228,059 | $7,575,000 | 0.27% |
| NEXTHERA CAPITAL LP | 200,000 | $680,000 | 0.13% |
| LINCOLN CAPITAL CORP | 37,280 | $127,000 | 0.10% |
| Meridian Wealth Management, LLC | 49,600 | $169,000 | 0.07% |
| Rubric Capital Management LP | 199,883 | $680,000 | 0.07% |
| Virtus ETF Advisers LLC | 155,009 | $527,000 | 0.05% |